Company intelligence / Profile preview

Tririver Capital

Shanghai, Shanghai, Chinatririvercapital.com ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Tririver Capital is a Shanghai-based investment and advisory firm focused on venture capital and private equity in life sciences, healthcare, biotechnology, medical devices, medical services, and related sectors. The firm invests across early to later-stage rounds in China’s health innovation ecosystem. It has acted as financial advisor on cross-border deals and has supported biopharma partnerships between Chinese firms and international drug developers[1][2][6].

Modalities: Small moleculePeptidesAntibody
Industry: Investors

Partnerships

Provectus Biopharmaceuticals – advisory agreement to help identify distribution/joint venture partners in China for PV‑10 oncology drug candidate

Beyond the preview

Go deeper on Tririver Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tririver Capital.

Explore the full profile